Thyroid hormone has been implicated as an important factor in rodent development. We have used a strain of mice with a recessive mutation producing congenital primary hypothyroidism (C.RF/J-hyti +) to study the effects ofthyroid hormone on developmental changes in the expression of genes encoding a number ofproteins involved in lipid metabolism and transport. Total cellular RNA was prepared from the small intestine and liver of hyt/hyt mice and their unaffected littermates ( + /?) at various times during postnatal development.
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RNA blots were probed with apolipoprotein A-I, A-HI, A-IV, B, and E cDNAs plus cDNAs encoding the low density lipoprotein receptor, 3-hydroxy-3-methylglutaryl coenzyme A reductase, and three cytoplasmic hydrophobic ligand-binding proteins (two fatty acid-binding proteins and a protein that binds all-trans-retinol). Hypothyroidism results in small changes (1.5-to 5-fold) in the concentration of many of these mRNAs in liver and small intestine between postnatal days 15 and 50. A much greater tissue-specific effect was noted on apolipoprotein B (apoB) gene expression. In euthyroid + /? animals, apoB mRNA levels fall by a factor of 30 in liver between days 20 and 35 without a comparable decrease in the small intestine. This liver-specific decrease does not occur in hyt/hyt animals. The normal decrease in hepatic apoB mRNA levels is accompanied by a decrease in plasma apoB-100 but not apoB-48. No reduction in either form of plasma apoB was noted in hyt/hyt animals. Mutant hyt/hyt mice given thyroxine from birth to 35 days had liver apoB mRNA levels comparable to those in + /?
littermates. In contrast, hepatic apoB mRNA concentrations did not fall to normal levels in hyt/hyt mice given thyroxine from postnatal days 15 to 35 . All treatment groups have comparable levels of plasma corticosteroids. These data suggest that (i) there is a critical period or a required response time during postnatal development for thyroid hormone action on apoB gene expression, (it) thyroid hormone's effect on apoB is tissue specific, and (iii) the hyt/hyt mouse represents a useful system to evaluate the developmental effects of thyroid hormone on specific gene expression.
Since the association between cretinism and abnormal thyroid gland morphology was established (1, 2) , the products of the thyroid gland have been recognized as important effectors of normal growth and development. Although postnatal brain maturation is the developmental program that is most commonly appreciated to be dependent upon the presence of thyroid hormone, it is not alone. Other organ systems, such as the rodent gastrointestinal system, have shown alterations in their developmental patterns when subjected to thyroid hormone excess or deficiency. Remarkable changes in cell number, type, and specific gene expression have been documented in the developing intestine and liver. In rodents, many of these changes [e.g., alterations in the activities of hydrolases located in the brush border of intestinal epithelial lining cells (enterocytes) or changes in the levels of hepatic enzymes involved in gluconeogenesis and fatty acid oxidation] occur at the suckling-weaning transition concomitant with an increase in the plasma levels of thyroxine (T4) and corticosterone. The act of weaning itself does not appear to be the inducing factor since many of these changes can occur during the same time period even when weaning is delayed (for review, see ref.
3). Studies with rats made hypothyroid with 6-propyl-2-thiouracil or by surgical removal of the thyroid gland have shown that thyroid hormone is involved in the developmental alterations in the activities of at least some of these enzymes (3, 4) .
Drug or surgically induced hypothyroidism represents one commonly used approach for assessing the contribution of thyroid hormone to developmental changes in specific gene expression. Another approach, which is described in this report, employs a mutant strain of congenitally hypothyroid mice named C.RF/J-hyt! + (5) . The hyt mutation is recessive and has been mapped to a single locus on chromosome 12. Mice homozygous for this mutant gene (hyt/hyt) are characterized by retarded growth, infertility, mild anemia, and mildly elevated serum cholesterol (5) . A number of observations have established that these animals suffer from primary hypothyroidism arising from defective development of the thyroid gland (5, 6) . Histologic examination of fetal hyt/hyt mice has shown that this defective development is first apparent at day 18 of the 20-day gestation period (6 Mice were sacrificed between 1000 and 1200 by decapitation. Their liver and small intestine were removed and immediately frozen in liquid N2. Total cellular RNA was isolated from frozen pulverized tissues by using guanidine thiocyanate (12) . The integrity of each RNA sample was verified by denaturing formaldehyde/agarose gel electrophoresis (13) . Dot blots were prepared by applying four amounts of each tissue RNA sample (0.5-3 ,ug) to nitrocellulose filters as described (14) . Blots were probed with 32P-labeled (15) cloned cDNAs encoding rat apoA-I (16), human apoA-II (17) , rat apoA-IV (18), rat apoB (19) , mouse apoE (20) , rabbit LDL-R (21), rat HMG CoA reductase (22) , rat liver fatty acid-binding protein ( (26) . Only data in the linear range of film sensitivity were used.
Immunoblot Analysis of Plasma apoB-100 and -B-48. Proteins contained in 2-/.l samples of serum were fractionated by electrophoresis through 5% polyacrylamide gels containing 0.5% NaDodSO4 (27) and then electrophoretically transferred to nitrocellulose filters at 150 mA for 15-20 hr as described (28) . Blots were blocked with Blotto buffer (29, 30) and then incubated for 30 min at 230C with a 1:1000 dilution (in Blotto) of polyclonal, monospecific rabbit anti-rat apoB serum (31) (25) plus a cDNA that encodes CRBP II that is expressed in enterocytes (9) . The results of this survey are presented in Fig. 1 .
Most of the differences in specific mRNA levels between normal (+ /?) and homozygous (hyt/hyt) littermates were small (1.5-to 5-fold). Some of these differences appear to reflect developmental delays that exhibit tissue specificity.
For example, in + /? euthyroid mice, apoA-I mRNA levels peak in the small intestine and liver on day 17 and begin to decline by postnatal day 20. In mutant hyt/hyt mice (Fig. 1) , this normal decline in apoA-I mRNA is delayed -3 days in intestine and as much as 18 days in liver. A similar delay may be occurring with HMG CoA reductase mRNA in liver. CRIP mRNA increases in normal animals at the suckling-weaning transition (i.e., between days 15 and 20). This change in CRIP mRNA levels is delayed in the intestine of hyt/hyt mice (Fig.  1) . Another pattern encountered was a more extended delay or absolute halt in the developmental progression of specific mRNA changes. This is exemplified in Fig. 1 in LDL-R mRNA was tissue specific: no statistically significant differences were noted in the intestines of comparably aged hyt/hyt and + /? mice.
Other types of changes in mRNA accumulation are also encountered in hyt/hyt mice. A modest increase in intestinal apoA-IV mRNA concentrations occur in the hyt/hyt mice at all time points surveyed after day 12. With some mRNAs (e.g., L-FABP and I-FABP), even though there are statistically significant differences in levels at some time points, it is not possible to make any generalization as to the developmental pattern. Finally, the absence of any significant change in CRBP II and apoA-II mRNA levels in intestinal RNA prepared from hyt/hyt and + /? animals during postnatal development suggests that alterations in the concentrations of other mRNAs do not reflect general increases or decreases in total mRNA levels in this tissue.
The Effects ofHypothyroidism on Developmental Changes in apoB Gene Expression. The most striking effect of hypothyroidism in hyt/hyt mice was seen with apoB. A single apoB gene codes for two serum proteins that are associated with chylomicrons (apoB-48), very low density lipoproteins, and low density lipoproteins (apoB-100). A distinctive co-or post-transcriptional nucleotide alteration results in the introduction of a stop codon into the middle of the apoB-100 gene transcript (35) . This modified mRNA encodes apoB-48. ApoB-48 (210 kDa) is produced in mouse liver and small intestine whereas apoB-100 (512 kDa) is synthesized only in the liver (ref. 10 Posatal Age (Day) Proc. Natl. Acad. Sci. USA 85 (1988) trations remain elevated at 20, 35, and 50 days. The net result is a 30-to 50-fold higher concentration of apoB mRNA in the livers of50-day-old hyt/hyt mice compared to their euthyroid + /? littermates ( Fig. 2A) .
Studies by Lusis et al. (30) have indicated that levels of apoB mRNA do not correlate with plasma apoB concentrations in various strains of mice. To examine the effects of the observed alterations in apoB mRNA levels in hyt/hyt mice on plasma apoB, we prepared immunoblots of samples of serum proteins fractionated by denaturing polyacrylamide gel electrophoresis. Sera were examined from 17-, 35-, and 50-dayold hyt/hyt and comparably aged + /? littermates (Fig. 2B) . The decrease in hepatic apoB mRNA observed in + /?
animals is followed by a decrease in the serum levels of apoB-100 but not apoB-48. ApoB-100 decreases by a factor of 5 from day 17 to day 35 in normal animals and is no longer detectable in the serum of 50-day-old + /? mice. In hyt/hyt animals, there is a decrease by only a factor of 2 in apoB-100 between day 17 and 35, and no reduction between days 35 and 50. Serum apoB-48 levels are the same in hyt/hyt and euthryoid + /? mice at 17 and 35 days and are reduced slightly at 50 days in hyt/hyt animals (Fig. 2B) .
The difference between serum apoB levels in hyt/hyt and + /? animals does not appear to be a major contributory factor to the mild elevation in serum cholesterol observed in the mutant mice. At 17 days of age, although serum apoB levels are still identical in hyt/hyt and + /? animals, hyt/hyt serum cholesterol levels are significantly elevated (hyt/hyt, 242 + 14 mg/dl; + /?, 181 + 12 mg/dl) and do not diverge any further at 35 days as apoB-100 levels begin to decline in + /? animals (hyt/hyt, 176 ± 24 mg/dl; + /?, 141 ± 5 mg/dl).
"Rescuing" the Normal apoB Phenotype in hyt/hyt AfimaLs. One explanation for the apoB phenotype in hyt/hyt animals is that the alteration in hepatic apoB mRNA and serum protein concentration is a feature of the hyt mutation that is unrelated to their thyroid function. To examine this possibility, restoration of normal apoB mRNA and protein levels was attempted by supplying exogenous thyroid hormone to homozygous mutant mice. The offspring of homozygous matings were given thyroid hormone from postnatal days 15 to 35 or from birth to 35 days either orally in the form of dessicated thyroid powder or by intraperitoneal injection of T4 (Fig. 3) . When thyroid hormone was supplied from birth to 35 days by both supplementation methods, apoB mRNA levels in the livers of 35-day-old hyt/hyt mice were reduced to levels approximating those found in normal (+ /?) animals. However, apoB mRNA levels were only reduced slightly when thyroid hormone was supplied from 15 to 35 days (Fig.  3) . Corresponding changes were observed in serum apoB-100 (data not shown). These results suggest two possibilities: (i) there is a critical period before day 15 during which thyroid hormone must be present for the normal reduction in hepatic apoB mRNA concentration to occur or (it) there is a required response time (>20 days) between exposure to T4 and the decline in apoB mRNA levels.
Although it appears that the presence of thyroid hormone was critical for this developmental reduction in hepatic apoB mRNA levels, the possibility remains that it may not be the final hormonal effector of this alteration. Henning (36) has argued persuasively that many developmental changes that appear to be thyroid hormone dependent may in fact be corticosteroid dependent since thyroid hormone deficiency eliminates the normal increase in plasma corticosterone that occurs during the suckling-weaning transition. Early work with hyt/hyt mice demonstrated that the adrenocortical X-zone was poorly developed in 36-to 64-day-old mice (37) .
To determine whether the effect of hypothyroidism on apoB gene expression in hyt/hyt mice might be the result of corticosteroid deficiency, sera from + /? and hyt/hyt littermates were assayed for total T4 and two corticosteroids, Rescue experiments were performed on the offspring from homozygous hyt/hyt matings. Mutant hyt/hyt mice were fed a diet supplemented with 0.025% dessicated thyroid powder to correct their infertility (6) . This supplemented diet was discontinued at the first sign of pregnancy. Offspring were treated either from birth to 35 days ofage or from days 15 to 35 (stippled bars). For the birth to 35-day peroral rescue experiments, a chow diet supplemented with 0.025% dessicated thyroid powder was given to mothers when the pups were born ("galactotherapy" of hyt/hyt animals is discussed in ref. 7) . These pups were subsequently weaned to supplemented chow. For the 15-to 35-day peroral rescue experiments, the supplemented diet was not provided to either mother or pups until the postnatal day 15. An intraperitoneal injection of either saline (50 Il) or T4 (0.1 1Ag in 50 ,ug of saline) was administered daily (at 1300) to separate groups of animals either from birth to day 35 or from day 15 to day 35. The lactating mothers of this treatment group were not given a supplemented chow diet. For all treatment groups, hyt/hyt animals given thyroid hormone reached near normal size. Results obtained from representative litters are shown. However, in our experience, galactotherapy resulted in large variations in liver apoB mRNA levels from litter to litter. For this reason, we believe that injection is the preferred route of T4 replacement in young animals. Open bar, euthyroid + /? mice; solid bar, untreated hyt/hyt mice. cortisol and corticosterone (Fig. 4) 
